Case Report: Colorectal cancer metastasis to a cervical lymph node – an unusual source of a neck lump

Introduction

Cervical lymphadenopathy refers to the pathological enlargement of cervical lymph nodes. Generally, it is reactive, benign and self-limiting, but in some patients is a presenting sign of an occult malignancy.

Malignant lymphadenopathy may be primary (Hodgkin lymphoma, Non-Hodgkin lymphoma) or metastatic (squamous cell carcinomas of the skin and upper aerodigestive tract or salivary/thyroid gland carcinomas). Metastatic spread is typically along lymphatic channels from the head and neck, but in 1% of cases originates more distally (most commonly from the breast, lung, kidney, tests and cervix)¹.

Colorectal cancer accounts for 10.2% of cancer incidence worldwide, with nearly two million cases diagnosed in 2018 and makes up 9.2% (881,000) of all cancer-related deaths².

As with many malignancies, the development of metastatic disease is associated with a poorer prognosis. Approximately 25% of patients with colorectal cancer will have metastases at the time of diagnosis, and approximately half will go on to develop them³. Colorectal malignancy can spread distally via lymphatic or haematogenous routes and typically metastasises to the liver, lung, bone, brain and peritoneum⁴.

Here we present the case of a patient presenting with a neck lump that was ultimately found to be a metastatic caecal adenocarcinoma. The case describes an unusual pattern of disease spread, both anatomically and by histological subtype. The presence of cervical nodal disease in the absence of solid organ metastasis is particularly unusual.

Case presentation

A 73-year-old female patient presented with small bowel obstruction and underwent an emergency right hemicolectomy for a caecal mass.

The patient had multiple comorbidities: chronic obstructive pulmonary disease, hypertension, deep vein thrombosis, non-ST-elevation myocardial infection, coronary artery bypass graft, osteoarthritis and a hiatus hernia. The patient was a current smoker with a 13-pack year history and minimal alcohol consumption.

Post-operative histology described a poorly differentiated caecal adenocarcinoma with clear resection margins and 4/20 regional nodes involved (TNM staging, T4N2M0). The colorectal multidisciplinary team (MDT) meeting recommended adjuvant chemotherapy to reduce the risk of cancer recurrence and treat any micro-metastatic disease. The recommendation was to complete eight cycles of capecitabine (130mg/m²) and oxaliplatin (1000 mg/m² twice daily) chemotherapy over six months. Unfortunately, the patient only completed one cycle, declining further treatment due to the severity of side effects.

At one-year follow up, colonoscopy and a computerised tomography (CT) abdomen demonstrated no evidence of recurrent disease. Three years later, on surveillance imaging, para-aortic lymph node metastases were detected on positron emission tomography (PET) scanning. The patient underwent external beam para-aortic radiotherapy 50.4 Gy in 28 fractions, which was well tolerated, and was discharged to regular surveillance.

Three years later, a rapidly enlarging painless left-sided neck lump was detected. There was no dysphagia, odynophagia, dysphonia, loss of appetite or weight loss. On examination, there was a palpable small level IV neck lump which was smooth, non-fluctuant and non-tethered to underlying structures.

Investigations

Routine blood tests, including full blood count, liver function and renal function, were unremarkable. Carcinoembryonic antigen, a tumour marker for colorectal carcinoma, was elevated at 24.0 mg/L (normal range <2.5 mg/L).

Ultrasound of the lump showed a 6-mm level IV cervical lymph node with intranodal calcifications, loss of hilar architecture and increased vascularity suspicious for malignancy.

Cytology from fine-needle aspiration of the node under ultrasound guidance showed clusters of atypical cells with pleomorphic nuclei and a moderate amount of cytoplasm. Immunohistochemical analysis of the cell block preparation showed cells which were positive for cytokeratin AE1/AE3 and CDX2. AE1/AE3 is an antibody-based assay which reacts with epithelial based tissues, and CDX2 is an intestine-specific transcription factor that is highly sensitive and specific for adenocarcinomas of intestinal origin⁵.

Whole-body PET-CT showed elevated tracer uptake in an 8.4mm left level IV LN, and in a second 7-mm left supraclavicular lymph node with no further evidence of thoracic or abdominal recurrent disease (See Figure 1).

Figure 1. Positron emission tomography/computerised tomography demonstrating elevated tracer uptake in an 8.4-mm left level IV lymph node (red arrow).

Treatment

On day 35 following re-presentation, the patient was discussed at the Head and Neck Cancer MDT in conjunction with the Colorectal Cancer MDT, the recommendation was made for a selective neck dissection of levels 2, 3, 4, and 5. The surgery went without complication, and the patient was discharged the following day.

Histology from the dissection showed 6/20 lymph nodes with metastatic deposits of poorly differentiated adenocarcinoma. There was with evidence of intracellular mucous and positive staining for CK20 and CDX-2. Immunohistochemical analysis confirmed an intestinal origin (Figure 2).

Figure 2. Histology from left neck dissection showing metastasis of poorly differentiated carcinoma in lymph node (40X magnification).

(a) Atypical cells with pleomorphic nuclei demonstrated Hematoxylin and Eosin stain. (b) Immunohistochemistry for CK20 with characteristic cytoplasmic and nuclear staining. (c) Immunohistochemistry for CDX-2. (d) Intracellular mucus detected on special stain (ABPAS) confirming glandular (adenocarcinoma). ABPAS is an Alcian Blue stain which demonstrates intra and extracellular mucous.

Discussion

Pathological cervical lymphadenopathy is most commonly due to metastasis from malignancies that originate in the head and neck. Common primary sites include skin cancers, salivary gland tumours, thyroid carcinomas and squamous cell carcinomas of the upper aerodigestive tract¹.

Generally, malignancies metastasise along predictable routes of lymphatic drainage to nodal areas, which has led to the development of neck levels (I-VII) that guide surgical management. Investigations can be targeted to the likely primary site based on the location of the lymphadenopathy; for example, level I nodes drain the oral cavity, submandibular gland, lip and anterior nasal cavity.

The presentation of metastasis from more distant sites, particularly infraclavicular, is more challenging to account for as there is often no apparent lymphatic route. A potential mechanism of spread is via obstruction of the thoracic duct.

The thoracic duct is the largest lymphatic vessel in the body. It extends from the cisterna chyli at the level of the second lumbar vertebrae and ascends through the abdomen and thorax to terminate into the left subclavian vein. It receives afferents from the thorax, abdomen and pelvis, and therefore provides a potential route for the spread of disease to left supraclavicular lymph node. Virchow’s node is the eponymous name given to this node, and Trosier’s sign refers to it pathological enlargement, typically due to gastric or pulmonary malignancy⁷. Lymphatic drainage of the head and the neck is via the superficial and deep lymphatic vessels which converge to form the right and left jugular lymphatic trunks. Vessels from the right terminate in the right lymphatic duct and those on the left, in the thoracic duct. Lymphatic obstruction at supraclavicular or lower cervical nodes can, therefore, result in the retrograde spread of abdominal or thoracic disease to higher cervical or even contralateral lymph nodes¹.

Different histological subtypes of colorectal cancer also appear to have predilections for distinct metastatic sites. In an autopsy study of 1675 patients with metastatic disease, Hugen et al.⁸ found that adenocarcinomas preferentially metastasised to the liver, while mucinous and signet ring cell carcinomas were more frequently associated with peritoneal metastasis. Signet ring cell carcinomas metastasised to distant lymph nodes more frequently than adenocarcinomas and mucinous carcinomas. Interestingly, there appeared to be no significant difference in the rate of pulmonary metastasis between histological subtypes⁸.

The study also demonstrated a difference in metastases distribution based on the original tumour site. While both primarily metastasised to the liver, colonic malignancies were more likely to present with intra-abdominal metastasis (peritoneal, omental or ovarian) and rectal cancers were more frequent in extra-abdominal sites (lung, brain). The venous drainage of the rectum can explain its more wandering metastatic spread. While the superior and inferior mesenteric veins drain the colon and upper two-thirds of the rectum into the portal venous system; the lower third of the rectum is drained by the middle and inferior rectal veins which bypass the liver and directly enter the inferior vena cava. Our case is therefore made more unusual by the fact it was neither rectal or a signet ring cell carcinoma; so distant cervical metastasis is unexpected. In patients with only one distant metastasis, the site of metastases also appears to be an important prognostic factor. For example, thoracic metastases are associated with longer median survival than peritoneal, bone or nervous system metastases⁹.

An understanding of the different patterns of metastatic spread between subtypes is of clinical importance as it may affect both immediate management and follow up techniques. In line with guidance from the National Institute for Health and Care Excellence, patients routinely undergo at least two CT scans of the chest, abdomen pelvis in the first three years after treatment¹⁰. Given the findings of Hugen et al., a case could be made for imaging additional sites or using other imaging modalities such as PET-CT in higher-risk subtypes such as signet ring cell or mucinous carcinoma.

Several case reports have been published on the metastatic spread of colorectal carcinoma to the thyroid gland^11–13, but isolated metastatic spread to cervical lymph nodes is rare, and treatment decisions are made on a case by case basis. Aksel et al.⁴ reported on a case of cervical lymphadenopathy as the presenting feature of undiagnosed sigmoid colon carcinoma. The patient was treated with simultaneous resection of the colonic primary and left neck node dissection. Postoperatively the patient received adjuvant folinic acid/fluoronacil/oxaliplatin chemotherapy and was disease-free at nine-month follow up⁴. Ochi et al.¹⁴ reported on a case of metastatic recurrent sigmoid colon cancer to Virchow’s lymph node. This was managed non surgically with systemic chemotherapy and radiotherapy, which achieved a complete response and no recurrence at the ten-month follow-up¹⁴.

In conclusion, although most metastatic lymphadenopathy originates from head and neck primaries, clinicians should always consider the possibility of more remote disease and not underestimate the importance of a detailed past medical history and systems review. Management of metastatic disease to the neck should be discussed by the relevant cancer MDTs and may involve surgical resection and chemotherapy with or without radiotherapy.

Learning points/take home messages

Data availability

All data underlying the results are available as part of the article and no additional source data are required.

Consent

Written informed consent for publication of clinical details and clinical images was obtained from the patient.